Smiths Group (SMGZY) Earns Overweight Rating from Analysts at Barclays

Analysts at Barclays started coverage on shares of Smiths Group (OTCMKTS:SMGZY) in a research report issued on Tuesday. The firm set an “overweight” rating on the business services provider’s stock.

SMGZY has been the topic of several other research reports. Zacks Investment Research upgraded shares of Smiths Group from a “hold” rating to a “buy” rating and set a $27.00 target price on the stock in a research report on Thursday, January 25th. Morgan Stanley upgraded shares of Smiths Group from an “underweight” rating to an “equal weight” rating in a research report on Wednesday, December 13th.

Shares of Smiths Group (SMGZY) opened at $21.52 on Tuesday. Smiths Group has a 52-week low of $18.70 and a 52-week high of $23.87. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.82 and a current ratio of 2.34.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/13/smiths-group-smgzy-earns-overweight-rating-from-analysts-at-barclays.html.

About Smiths Group

Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply